Certara (NASDAQ:CERT) Trading Down 4.3%

Certara, Inc. (NASDAQ:CERT) fell 4.3% on Tuesday . The stock traded as low as $13.75 and last traded at $13.75. 794,592 shares traded hands during trading, an increase of 46% from the average session volume of 543,688 shares. The stock had previously closed at $14.37.

Analysts Set New Price Targets

Several research firms have weighed in on CERT. KeyCorp upgraded shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective on the stock in a research report on Wednesday, April 10th. JMP Securities began coverage on shares of Certara in a research report on Thursday, April 4th. They set a “market perform” rating on the stock. UBS Group lifted their price objective on shares of Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research report on Friday, March 1st. Leerink Partnrs reiterated a “market perform” rating on shares of Certara in a research report on Monday, February 26th. Finally, Jefferies Financial Group lifted their price objective on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research report on Friday, March 1st. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $20.06.

Certara Stock Performance

The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.26 and a current ratio of 3.26. The firm’s 50 day moving average is $16.72 and its 200-day moving average is $17.02. The firm has a market cap of $2.15 billion, a price-to-earnings ratio of -34.28, a price-to-earnings-growth ratio of 5.00 and a beta of 1.58.

Certara (NASDAQ:CERT) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The business had revenue of $96.65 million during the quarter, compared to analyst estimates of $94.48 million. Sell-side analysts anticipate that Certara, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Activity at Certara

In other Certara news, insider Patrick F. Smith sold 14,427 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the transaction, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Certara news, SVP Richard M. Traynor sold 3,000 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Patrick F. Smith sold 14,427 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total transaction of $243,094.95. Following the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The disclosure for this sale can be found here. 2.39% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Pineridge Advisors LLC bought a new position in shares of Certara during the 4th quarter worth about $28,000. Global Retirement Partners LLC increased its holdings in shares of Certara by 5,306.3% during the 1st quarter. Global Retirement Partners LLC now owns 1,730 shares of the company’s stock worth $31,000 after purchasing an additional 1,698 shares during the period. YHB Investment Advisors Inc. bought a new position in shares of Certara during the 1st quarter worth about $47,000. Covestor Ltd increased its holdings in shares of Certara by 14,940.0% during the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after purchasing an additional 3,735 shares during the period. Finally, Pacer Advisors Inc. increased its holdings in shares of Certara by 1,704.0% during the 4th quarter. Pacer Advisors Inc. now owns 12,754 shares of the company’s stock worth $224,000 after purchasing an additional 12,047 shares during the period. Institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.